文献速递生殖医学产科

辅助生殖技术相关的妊娠物残留危险因素

Assisted reproductive technology-associated risk factors for retained products of conception.
PubMed 文献 · Fertil Steril · 2023-11-29

基于日本辅助生殖技术登记库2007至2017年369608例单胎活产,评估新鲜与冻融胚胎移植后妊娠物残留的危险因素。共132例(0.04%)发生产后妊娠物残留,其中122例(92.4%)发生于冻融胚胎移植周期;冻融周期中激素替代周期为最大危险因素(调整比值比4.9,95%CI 2.0-12.4)。

要点

  • 妊娠物残留总体发生率0.04%,92.4%发生于冻融胚胎移植周期。
  • 冻融周期中激素替代周期是最大危险因素(调整比值比4.9,95%CI 2.0-12.4)。
  • 妊娠物残留者阴道分娩比例78.0%,高于无妊娠物残留者的61.1%。

核心结论

  • 大多数妊娠物残留病例来源于冻融胚胎移植,激素替代周期是该组中最大的危险因素。

研究设计与样本

  • 基于登记库的回顾性队列研究,数据来自日本辅助生殖技术登记库2007至2017年新鲜与冻融胚胎移植后的369608例单胎活产。

主要发现

  • 共132例(0.04%)发生产后妊娠物残留,其中122例(92.4%)发生于冻融胚胎移植周期。
  • 妊娠物残留者阴道分娩比例为78.0%,无妊娠物残留者为61.1%;合并胎盘植入谱系疾病比例分别为24.2%与0.45%。
  • 冻融胚胎移植中,移植胚胎阶段、激素替代周期和辅助孵化与妊娠物残留风险显著增加相关。
  • 激素替代周期为最大危险因素(调整比值比4.9,95%CI 2.0-12.4);激素替代周期后妊娠物残留发生率为0.05%(51/97958),自然周期后为0.01%(5/47079)。
  • 亚组分析显示,在无多囊卵巢综合征和无排卵病例以及阴道分娩病例中,激素替代周期和辅助孵化仍是显著危险因素,但在剖宫产病例中不显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate assisted reproductive technology-associated risk factors for retained products of conception among live births. DESIGN: Registry-based retrospective cohort study. SETTING: Not applicable. PATIENT(S): Cycle-specific data for a total of 369,608 singleton live births after fresh and frozen-thawed embryo transfers (FETs) between 2007 and 2017 were obtained from the Japanese assisted reproductive technology registry. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Retained products of conception after delivery. Odds ratios and 95% confidence intervals for risk factors associated with retained products of conception during fresh and frozen cycles. RESULT(S): In total, 132 deliveries (0.04% of eligible assisted reproductive technology registry deliveries) had retained products of conception; 122 (92.4%) of these deliveries occurred after FET transfer cycles. Cases with retained products of conception were significantly more likely to have undergone vaginal delivery than cases without retained products of conception (78.0% vs. 61.1%); they were also more likely to have been complicated with the placenta accreta spectrum (24.2% vs. 0.45%). Among patients undergoing FETs, factors associated with a significantly increased risk of retained products of conception were embryo stage at transfer, use of hormone replacement cycles, and assisted hatching. Use of hormone replacement cycles represented the largest risk factor (adjusted odds ratio, 4.9; 95% confidence interval, 2.0-12.4), such that retained products of conception occurred in 0.05% (51 of 97,958) of deliveries after hormone replacement cycles but only 0.01% (5 of 47,079) of deliveries after natural cycles. Subgroup analysis showed that hormone replacement cycles and assisted hatching remained significant risk factors for retained products of conception in cases without polycystic ovary syndrome and anovulation and cases with vaginal delivery, but not cases with cesarean section. Among fresh embryo transfers, an increased number of retrieved oocytes was the only significant risk factor for retained products of conception. CONCLUSION(S): Our analyses demonstrated that most of the cases involving retained products of conception were derived from FETs, and we identified the use of hormone replacement cycles as the largest risk factor for retained products of conception within this group.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Jwa SC, Takahashi H, Tamaru S, et al. Assisted reproductive technology-associated risk factors for retained products of conception. Fertil Steril. 2023. PMID: 38036239. doi:10.1016/j.fertnstert.2023.11.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。